Arcutis Biotherapeutics Inc. (ARQT)

Business: Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

IPO Date: 31-Jan-2020

Pres, CEO & Director: Mr. Todd Franklin Watanabe M.A.

Co-Founder & Independent Director: Dr. Bhaskar Chaudhuri Ph.D.

Listing: NASDAQ: ARQT

Country: United States

Headquarters: Westlake Village, CA

Website: https://www.arcutis.com

Market cap: $1,137.37 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-234.64 Mln

Cash: $343.60 Mln

Total Debt: $77.86 Mln

Insider's Holding: 4.34%

Liquidity: Low

52 Week range: $13.59 - 27.45

Shares outstanding: 51,418,000

5 Years Aggregate:

• CFO: $-348.36 Mln
• EBITDA: $-409.38 Mln
• Net Profit: $-408.26 Mln